Upper respiratory tract infection.
Del Mar
Chris B
CB
University of Queensland, Brisbane, Australia.
Glasziou
Paul
P
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D020900:Echinacea; D019317:Evidence-Based Medicine; D005194:Family Practice; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D014663:Nasal Decongestants / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D015032:Zinc / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D015032:Zinc; D001205:Ascorbic Acid